Patents by Inventor Etsu GO

Etsu GO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKER FOR PARKINSON'S DISEASE AND USE THEREOF
    Publication number: 20180045741
    Abstract: An antibody has as a target molecule a ubiquitin protein comprising a phosphorylated serine residue at position 65. In addition, a method is provided for specifically detecting Parkinson's disease at an early stage, in which a target molecule is a ubiquitin protein comprising a phosphorylated serine residue at position 65, a pharmaceutical composition for definitively treating or preventing Parkinson's disease, and a method for screening for the pharmaceutical composition.
    Type: Application
    Filed: October 5, 2017
    Publication date: February 15, 2018
    Inventors: Noriyuki Matsuda, Fumika Koyano, Kei Okatsu, Etsu Go, Mayumi Kimura, Yasushi Saeki
  • Biomarker for parkinson's disease and use thereof
    Patent number: 9804174
    Abstract: A antibody has as a target molecule a ubiquitin protein comprising a phosphorylated serine residue at position 65. In addition, a method is provided for specifically detecting Parkinson's disease at an early stage, in which a target molecule is a ubiquitin protein comprising a phosphorylated serine residue at position 65, a pharmaceutical composition for definitively treating or preventing Parkinson's disease, and a method for screening for the pharmaceutical composition.
    Type: Grant
    Filed: February 13, 2015
    Date of Patent: October 31, 2017
    Assignee: Tokyo Metropolitan Institute of Medical Science
    Inventors: Noriyuki Matsuda, Fumika Koyano, Kei Okatsu, Etsu Go, Mayumi Kimura, Yasushi Saeki
  • BIOMARKER FOR PARKINSON'S DISEASE AND USE THEREOF
    Publication number: 20170010285
    Abstract: A antibody has as a target molecule a ubiquitin protein comprising a phosphorylated serine residue at position 65. In addition, a method is provided for specifically detecting Parkinson's disease at an early stage, in which a target molecule is a ubiquitin protein comprising a phosphorylated serine residue at position 65, a pharmaceutical composition for definitively treating or preventing Parkinson's disease, and a method for screening for the pharmaceutical composition.
    Type: Application
    Filed: February 13, 2015
    Publication date: January 12, 2017
    Inventors: Noriyuki MATSUDA, Fumika KOYANO, Kei OKATSU, Etsu GO, Mayumi KIMURA, Yasushi SAEKI